Literature DB >> 3682853

Care of infants with esophageal atresia, tracheoesophageal fistula, and associated anomalies.

T M Holder1, K W Ashcraft, R J Sharp, R A Amoury.   

Abstract

One hundred consecutive patients with esophageal atresia or tracheoesophageal fistula, or both, were treated at The Children's Mercy Hospital during the past 14 years. Each patient was evaluated and a plan for therapy was formulated depending on the type and urgency of concomitant disease. Healthy patients were treated by primary repair. Those with respiratory disease were treated before repair by gastrostomy, upper pouch suction, and antibiotics. In the small premature infant and the patient with major associated anomalies, repair of the esophageal atresia and tracheoesophageal fistula was postponed by gastrostomy, upper pouch suction, and parenteral nutrition while the concomitant disease was treated. Fifteen patients with life-threatening associated anomalies required operation before esophageal repair and 13 of them survived. During the initial hospitalization two deaths related to esophageal atresia occurred, whereas three prerepair and two late (2 1/2 and 3 months) postrepair deaths related to associated anomalies occurred. Thus, 93 of the 100 patients left the hospital alive. The increased survival is due not only to improved care of esophageal atresia and tracheoesophageal fistula, but also to a more aggressive approach to the treatment of the serious associated anomalies.

Entities:  

Mesh:

Year:  1987        PMID: 3682853

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  15 in total

1.  Analysis of Prognostic Factors and Mortality in Children with Esophageal Atresia.

Authors:  Miroslav Vukadin; Djordje Savic; Aleksandar Malikovic; Danica Jovanovic; Maja Milickovic; Srdjan Bosnic; Aleksandar Vlahovic
Journal:  Indian J Pediatr       Date:  2015-03-01       Impact factor: 1.967

2.  The influence of congenital heart disease on survival of infants with oesophageal atresia.

Authors:  H Leonard; A M Barrett; J E Scott; C Wren
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

3.  Factors contributing to poor results of treatment of esophageal atresia in developing countries.

Authors:  S Agarwala; V Bhatnagar; M Bajpai; D K Gupta; D K Mitra
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

4.  Total anomalous pulmonary venous drainage complicated by tracheoesophageal fistula.

Authors:  Toru Okamura; Mitsugi Nagashima; Fumiaki Shikata; Takashi Higaki; Eiichi Yamamoto; Masaaki Ohta; Hidemi Takata
Journal:  Pediatr Cardiol       Date:  2011-06-09       Impact factor: 1.655

5.  Esophageal atresia and tracheo-esophageal fistula: a review.

Authors:  S Dave; M Bajpai; D K Gupta; S Agarwala; V Bhatnagar; D K Mitra
Journal:  Indian J Pediatr       Date:  1999 Sep-Oct       Impact factor: 1.967

6.  Tracheoesophageal fistula with esophageal atresia with absent external ear: a unusual association.

Authors:  Vijai D Upadhyaya; Ajay N Gangopadhyay; Punit K Srivastava; Zaheer Hasan; Shiv P Sharma
Journal:  Indian J Surg       Date:  2012-05-01       Impact factor: 0.656

7.  Development of a true primary repair for the full spectrum of esophageal atresia.

Authors:  J E Foker; B C Linden; E M Boyle; C Marquardt
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

8.  Tracheoesophageal fistula and amastia with other anomalies: an unusual association.

Authors:  Vijayendra Kumar; Ashwin V Apte; A N Gangopadhyay; Shailendra Singh
Journal:  Pediatr Surg Int       Date:  2004-05-11       Impact factor: 1.827

9.  The management of combined oesophageal and duodenal atresia.

Authors:  S Dave; E C P Shi
Journal:  Pediatr Surg Int       Date:  2004-09-11       Impact factor: 1.827

10.  An oblique anastomosis has more linear length than a transverse anastomosis of a tubular structure in oesophageal anastomosis.

Authors:  Muslim Yurtcu; Adnan Abasiyanik; Hamdi Arbag; Mehmet Oz
Journal:  Pediatr Surg Int       Date:  2009-01-08       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.